Summary
Updated Aug 30, 2026
Michael Thomas Heffernan files SEC Form 4 reports at enGene Therapeutics Inc. (ENGN). 5 SEC Form 4 filings on record going back to 2025, most recently on 17 June 2026.
Trading Pattern
InsiderAlpha's records for Michael Thomas Heffernan go back to 2025: 5 primary Form 4 filings, an average of 2.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael Thomas Heffernan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Ryan Sullivan - $3.34M of AVTX open-market activity in the last 12 months
- Mittie Doyle - $2.96M of AVTX open-market activity in the last 12 months
- Paul Varki - $1.51M of AVTX open-market activity in the last 12 months
- Jonathan Goldman - $163K of AVTX open-market activity in the last 12 months
- Mitchell Chan - $72K of AVTX open-market activity in the last 12 months
- Jennifer Riley - $52K of AVTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Michael Thomas Heffernan?
Michael Thomas Heffernan is a corporate insider of enGene Therapeutics Inc. (ENGN). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michael Thomas Heffernan submitted recently?
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Where can I see all of Michael Thomas Heffernan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Michael Thomas Heffernan and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial